Lymphoma  >>  OPB-31121  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OPB-31121 / Otsuka
NCT00511082: Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Unknown status
1
42
RoW
OPB-31121
Otsuka Beijing Research Institute, Otsuka Pharmaceutical Co., Ltd.
Non-Hodgkin's Lymphoma(NHL), Multiple Myeloma(MM)
09/09
12/09

Download Options